
Dong Xu, PhD, MS, curators' distinguished professor at the University of Missouri College of Engineering, discusses how artificial intelligence is being used to develop new drug therapies for medical treatments targeting cancers and other diseases.

Dong Xu, PhD, MS, curators' distinguished professor at the University of Missouri College of Engineering, discusses how artificial intelligence is being used to develop new drug therapies for medical treatments targeting cancers and other diseases.

One example that has already been done in the past relates to understanding how to better measure insulin persistence.

US providers report substantial disruptions in vital supplies of saline injections, prefilled syringes.

This month's OTC Cases focuses on heartburn, pinworm infection, and food poisoning.

Byron Yoshino, PharmD, CEO of Pharmacare Hawaii, discusses the rapidly growing home infusion space within Pharmacare Hawaii’s network of pharmacies.

The FDA has approved abrocitinib tablets to treat adults with moderate-to-severe, refractory atopic dermatitis.

In patients already using analgesics for pain control, pharmacists need to address medication adherence for improved osteoarthritis symptom control.

Issues like medication access and transportation cost all impact a patient's ability to have access to medications and use them safely and effectively.

The vaccine is also credited with saving more than $30 billion in health care costs and more than $40 billion in lost productivity.

Murray Aitken, executive director of IQVIA Institute for Human Data Science, discusses whether patient out of pocket costs rose in 2021, and what the implications may be for the health care system and for patients in 2022.

Independent pharmacies' constant battle over the years to try and get relief for NCPA members on these retroactive DIR fees have been really the number one issue.

Comfort Ear soothes dry, irritated ears.

Prezista is an protease inhibitor indicated for the treatment of HIV-1 infection in patients aged 3 years and older.

It's really opening up the world for pharmacists to develop more meaningful measures and get at patient reported and clinical outcome measures.

Health systems should review HHS’ action plan and determine how to leverage cost savings to help eradicate HCV.

Here are 9 tips for employers to address employees’ feeling of detachment, exhaustion, and reduced accomplishment.

This month's product news features beet gummies, nerve relief, and acne blemish patches.

Approved by the FDA in 2021, finerenone is the only non-steroidal mineralocorticoid receptor antagonist that reduces the risk of renal disease progression and cardiovascular events in adults with type 2 diabetes mellitus-mediated chronic kidney disease.

It's extremely important for pharmacists to be involved in helping care for people who have HIV.

Murray Aitken, executive director of IQVIA Institute for Human Data Science, discusses the implications of the increase in spending on medicines in the United States in 2021.

To maximize this challenging experience, pharmacy students should be eager to learn and inquisitive.

There is greater than a 98% probability that BI 1015550 was superior to placebo in slowing down the worsening of lung function in individuals with idiopathic pulmonary fibrosis.

Galcanezumab-gnlm (Emgality) is a CGRP antagonist indicated in adults for the preventive treatment of migraine and treatment of episodic cluster headache.

CalmEar is for dry, irritated, and itchy ears.

Kazano is a dipeptidyl-peptidase-4 (DPP-4) inhibitor and a biguanide combination product indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes.

Pharmacy performance measures allow the pharmacy to be more engaged in the patient's care that focuses on outcomes.

Of the 7 herpesviruses examined in the study, herpes simplex virus and cytomegalovirus were associated with incidence of prediabetes and diabetes among individuals with normal glucose tolerance.

They play an indispensable role in the vaccination and management of complex regimens.

There are many initiatives that are going on at PQA right now that are related to health equity.

But meeting regulatory requirements may entail a great deal of financial expertise and time.